PharmTech Inc. releases "California 2015 Serialization & e-Pedigree Strategic Planning Guide" for pharmaceutical and biopharmaceutical manufacturers

California's serialization and e-Pedigree mandates are due to take effect January 2015. In this Strategic Planning Guide, Michael Stewart of PharmTech provides insight on how to plan for regulatory compliance and how to identify and capture business value in the process. End Quote

"The value is in how you leverage the system, not the system itself."

(1888PressRelease) February 23, 2012 - The pharmaceutical industry is struggling with identifying the costs and benefits associated with implementing a serialization and e-Pedigree solution for their United States distribution channels.

PharmTech Inc. has released their complimentary California 2015 Serialization & e-Pedigree Strategic Planning Guide. This white paper will serve as a reference for the thought leadership and design of the technical architecture necessary to successfully plan and implement a serialization and product traceability solution in pharmaceuticals.

Included in the serialization strategy development guide are ways to identify additional business benefits by leveraging the newly created serialized data throughout the supply chain and product life cycle.

When asked about the delay in implementation of a solution by the pharmaceutical industry despite being pushed since 2004, Michael Stewart of PharmTech responded, "Pharmaceutical companies have been reluctant to move forward with Track & Trace, Serialization and e-Pedigree projects for a variety of valid reasons that I explain in the Guide. With the deadline for compliance less than 35 months away and the significant amount of advanced planning involved, pharmaceutical decision makers now understand that despite the challenges, Track & Trace of pharmaceuticals is not going to go away."

Mr. Stewart added "In PharmTech's engagements, we provide two decision paths for pharmaceutical clients, they can have a traceability system that gets them compliant OR a system that provides business value and competitive advantages for a similar cost with compliance as a secondary benefit. Many are so focused on getting compliant that they are missing the Acres of Diamonds that lay at their feet in how to leverage this opportunity if they plan for it. PharmTech helps them pick up those diamonds."

Complimentary copies are available by contacting PharmTech or the author directly.

http://www.pharmtechinc.com

###

Visit Pharmtech Inc. Website

space